Short answer
SBC Medical Group Holdings Inc (SBC) filed its Q2 2026 10-Q quarterly report on Aug 13, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $49M (up 13.4% year over year) with net income of $11M.
Q2 2026 key financials · XBRL
- Revenue
- $49M
- +13.4% YoY · +14.2% QoQ
- Net income
- $11M
- +335.0% YoY · −5.4% QoQ
- Operating margin
- 38.5%
- Gross margin
- 73.1%
- EPS (diluted)
- $0.10
- +400.0% YoY · −9.1% QoQ
Source: XBRL data from the SBC Medical Group Holdings Inc (SBC) Q2 2026 10-Q on SEC EDGAR. USD.
SBC Medical Group Holdings Inc Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $49.2M, up from $43.4M YoY
- Quarterly net income $10.7M, up from $2.5M YoY
- Six-month operating cash flow $31.7M vs $(6.4)M YoY
- Outlook: strengthening Shonan Beauty Clinic brand across Japan, Vietnam, Singapore and globally
Risk Factors
- Newly disclosed Nasdaq compliance risk triggered by director non-re-election on July 8, 2026
- Nasdaq cure period through July 9, 2027, or January 5, 2027 if the annual meeting occurs earlier
- Delisting risk could reduce securities liquidity and restrict future financing access
- Governance compliance risk from board independence and audit committee size requirements under Listing Rule 5605
- No material liquidity, debt maturity, currency, or concentration risks disclosed in provided section
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SBC Medical Group Holdings Inc quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.